
|Articles|March 19, 2017
Implications of Healthcare Reform Highlight AJPB Week in Review
Author(s)AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expanded Approval of Imiglucerase Expands Treatment Options for Type 3 Gaucher Disease
2
Study Finds No Evidence That Hormone Therapy Use Affects Dementia Risk in Postmenopausal Women
3
FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
4
FDA Draft Guidance Signals Shift Toward MRD, Complete Response as Accelerated Approval End Points in Multiple Myeloma
5


















